Laman UtamaBNTC • NASDAQ
add
Benitec Biopharma Inc
Tutup sebelumnya
$10.75
Julat hari
$10.68 - $10.94
Julat tahun
$2.70 - $13.29
Permodalan pasaran
250.27J USD
Bilangan Purata
69.34K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 5.79J | -3.16% |
Pendapatan bersih | -5.06J | 15.03% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -5.77J | 1.52% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 67.84J | 162.30% |
Jumlah aset | 68.77J | 154.22% |
Jumlah liabiliti | 4.59J | -3.18% |
Jumlah ekuiti | 64.18J | — |
Syer tertunggak | 23.22J | — |
Harga kepada buku | 2.99 | — |
Pulangan pada aset | -23.93% | — |
Pulangan pada modal | -25.87% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -5.06J | 15.03% |
Tunai daripada operasi | -4.59J | -0.20% |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | 21.66J | -22.44% |
Perubahan bersih dalam tunai | 16.98J | -27.41% |
Aliran tunai bebas | -3.08J | -36.95% |
Perihal
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Diasaskan
1997
Tapak web
Pekerja
16
